Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Bavarian Nordic AS's pretax income for the
three
months ended in Jun. 2026 was kr760 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jun. 2026 was kr1,981 Mil.
Bavarian Nordic AS's pretax margin was 37.34%.
During the past 13 years, Bavarian Nordic AS's highest Pretax Margin was 31.26%. The lowest was -71.24%. And the median was 9.58%.
During the past 13 years, Bavarian Nordic AS's highest Pretax Margin was 31.26%. The lowest was -71.24%. And the median was 9.58%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bavarian Nordic AS Pre-Tax Income Related Terms
Bavarian Nordic AS Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Bavarian Nordic AS's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BAVAC vs VRTX, REGN, MRNA: Pre-Tax Income Comparison
For the Biotechnology subindustry, Bavarian Nordic AS's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bavarian Nordic AS Pre-Tax Income vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Bavarian Nordic AS's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,981 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bavarian Nordic AS (CHIX:BAVAC) has a Pre-Tax Income of kr1,981 Mil as of Jun. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's Pre-Tax Income too high?
Bavarian Nordic AS's current Pre-Tax Income is kr1,981 Mil. Overall, Bavarian Nordic AS has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Pre-Tax Income compare to VRTX and REGN?
Bavarian Nordic AS's Pre-Tax Income of kr1,981 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current Pre-Tax Income is kr1,981 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr181.77, compared to a current price of kr216.80 — trading 19.3% above its estimated fair value. The current Pre-Tax Income is kr1,981 Mil. Bavarian Nordic AS's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Pre-Tax Income is kr1,981 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?
Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued.
The current stock price of kr216.80 is trading 19.3% above its estimated GF Value™ of kr181.77.
GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.
Key valuation signals for CHIX:BAVAC:
Pre-Tax Income: kr1,981 Mil
GF Value™: kr181.77 vs. price of kr216.80 (19.3% above fair value)
No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
78GF Score
Get the complete analysis for CHIX:BAVAC
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BAVAC has been successfully added to your 
